Phase II-IV studies
ICTU conducts national and international trials involving licensed drugs and Investigative Medicinal Products (IMP) in the following therapeutic areas
We aim to conduct trial feasibility as accurately as possible to set realistic recruitment targets and succeed in meeting these.
Details on recruitment outcomes in ICTU trials.
For an overview of ICTU's trial portfolio involving drugs/IMP see 'Current Trials'
Phase I studies
Imperial College Phase I trials are based at Hammersmith Hospital within the NIHR/Wellcome Imperial Clinical Research Facility (CRF). A dedicated study team comprising clinical research fellows, oncology trained research nurses, clinical project managers, data managers and research pharmacists, all GCP certified.
ICTU can work with Sponsors to identify the appropriate Imperial investigators to design and lead Phase I studies at Imperial.